3-Methoxypyridine-2-carboxylic acid, 97.0%, 250mg

2-Bromo-3-nitrothiophene, 95.0%, 250mg

3,5-Dimethoxybenzoylacetonitrile, 97.0%, 500mg

GC capillary column ROTI®Cap-1 MS, 15 m, 0.25 mm, 0.25 µm, 1 Piece(s)

1-(4-Boronophenyl)cyclopropanecarboxylic acid, 95.0%, 250mg

(R)-tert-Butyl (1-hydroxypent-4-yn-2-yl)carbamate, 95.0%, 5g

(S)-2-(3-(methoxycarbonyl)pyrrolidin-1-yl)acetic acid, 95+%, 50mg

Cerium(III) carbonate hydrate 99.99% 100 g

tert-Butyl 2-bromo-6,7-dihydropyrazolo[1,5-a]pyrazine-5(4H)-carboxylate, 97%, 1g

trans-4'-Propyl-(1,1'-bicyclohexyl)-4-carboxylic acid, 97%, 500g

Palladium(II) Acetate>98.0%(T)5g

2-(2-Methoxyethyl)pyridin-1-ium-1-olate, 250mg

(2S,2'S,3S,3'S)-3,3'-di-tert-Butyl-2,2'-diethyl-2,2',3,3'-tetrahydro-4,4'-bibenzo[d][1,3]oxaphosphole, 97%, 100mg